These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutations. Zaremba CM; Oliver D; Cavalier M; Fuda F; Karandikar NJ; Chen W Ann Diagn Pathol; 2012 Jan; 16(1):16-20. PubMed ID: 22050963 [TBL] [Abstract][Full Text] [Related]
64. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia. Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463 [TBL] [Abstract][Full Text] [Related]
65. An unusual case of acute leukemia. Fleury C; Passet M; Settegrana C; Simon L; Chapiro E; Trinquand A; Safra Zaghouani I; Uzunov M; Le Garff-Tavernier M; Armand M; Costopoulos M Ann Biol Clin (Paris); 2017 Jun; 75(3):339-347. PubMed ID: 28540857 [TBL] [Abstract][Full Text] [Related]
66. Lineage alteration in precursor B cell acute lymphoblastic leukemia following T cell lymphoblastic lymphoma. Gemma NW; Lovell MA; Bringelsen KA; Williams ME Leukemia; 1992 Dec; 6(12):1305-9. PubMed ID: 1333557 [TBL] [Abstract][Full Text] [Related]
67. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression. Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385 [TBL] [Abstract][Full Text] [Related]
68. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Am J Clin Pathol; 2004 Aug; 122(2):292-7. PubMed ID: 15323146 [TBL] [Abstract][Full Text] [Related]
69. Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma? Li S; Lew G Arch Pathol Lab Med; 2003 Oct; 127(10):1340-4. PubMed ID: 14521459 [TBL] [Abstract][Full Text] [Related]
70. Outcome and Clinical Significance of Immunophenotypic Markers Expressed in Different Treatment Protocols of Pediatric Patients With T-ALL in Developing Countries. Sayed DM; Sayed HAR; Raslan HN; Ali AM; Zahran A; Al-Hayek R; Daama SA; Al-Saber A Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):443-449. PubMed ID: 28624542 [TBL] [Abstract][Full Text] [Related]
71. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center. Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130 [TBL] [Abstract][Full Text] [Related]
72. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia. Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS; Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660 [TBL] [Abstract][Full Text] [Related]
73. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm. Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502 [TBL] [Abstract][Full Text] [Related]
74. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). Bene MC; Bernier M; Casasnovas RO; Castoldi G; Knapp W; Lanza F; Ludwig WD; Matutes E; Orfao A; Sperling C; van't Veer MB Blood; 1998 Jul; 92(2):596-9. PubMed ID: 9657760 [TBL] [Abstract][Full Text] [Related]
75. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia. Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427 [TBL] [Abstract][Full Text] [Related]
76. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079 [TBL] [Abstract][Full Text] [Related]
77. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype]. Liao HY; Sun ZY; Wang YX; Jin YM; Zhu HL; Jiang NG Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):561-567. PubMed ID: 32397018 [No Abstract] [Full Text] [Related]
78. Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia. Shimizu H; Handa H; Hatsumi N; Takada S; Saitoh T; Sakura T; Miyawaki S; Nojima Y Eur J Haematol; 2013 Apr; 90(4):301-7. PubMed ID: 23425206 [TBL] [Abstract][Full Text] [Related]
79. Comparison of flowcytometry-based scoring system for the diagnosis of early T precursor-acute lymphoblastic leukemia. Marballi Basavaraju D; Mishra S; Chhabra G; Chougule S Cytometry B Clin Cytom; 2023 Nov; 104(6):453-459. PubMed ID: 36892134 [TBL] [Abstract][Full Text] [Related]
80. Identification of new markers discriminating between myeloid and lymphoid acute leukemia. Haouas H; Haouas S; Uzan G; Hafsia A Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]